Nucleic acid sequences found in Drosophilia melanogaster that encode proteins essential for viability and method of use

Abstract

Within the unique Triplo-lethal region (Tpl) of the Drosophila melanogaster genome we have found a cluster of 20 genes encoding a novel family of proteins. This family is also present in the Anopheles gambiae genome and displays remarkable synteny and sequence conservation with the Drosophila cluster. The family is also present in the sequenced genome of Drosophila pseudoobscura, and homologs have been found in Aedes aegyptii mosquitoes and the honeybee (Apis mellifera), but it is not present in the sequenced genome of any non-insect species. Phylogenetic analysis suggests that the cluster evolved prior to the divergence of Drosophila and Anopheles (250MYA) and has been highly conserved since. The ratio of synonymous to nonsynonymous substitutions and the high codon bias suggest that there has been selection on this family both for expression level and function. We suggest that this gene family is Tpl, name it the Osiris family, and suggest possible functions. We also suggest that this family of proteins, due to the unique dosage sensitivity, and the lack of homologs in non-insect species, would be a good target for genetic engineering or novel insecticides. The proteins also present an excellent means to test compounds for use as possible insecticides.

Description

[0001] This application is a non-provisional application which claims priority from U.S. Provisional Patent Application Ser. No. 60 / 468,890 filed on May 8, 2003 and hereby incorporated by reference in its entirety.TECHNICAL FIELD [0002] The present invention relates to the fields of biotechnology and genetics, specifically to a cluster of nucleic acid sequences identified in the Drosophila melanogaster genome that are critical to the viability of the organism, are highly conserved, have unique sensitivity, and lack homologues in non-insect species. The invention particularly relates to the use of these nucleic acid sequences as effective targets for insecticides based on these features. BACKGROUND OF THE INVENTION [0003] Insect-borne diseases are a huge and growing problem in world health. The most serious of these is malaria, which affects over 300 million people each year, and kills over one million people. Although the mortality occurs among young children in sub-Saharan Africa, ...

AI Technical Summary

Benefits of technology

The present invention provides novel genes in insects that can be targeted by insecticides. These genes are critical to the viability of the insect and can be over expressed or under expressed to cause the insect's death. The invention also provides a method to test compounds for insecticidal use based on their ability to inhibit the expression of these genes. Additionally, the invention allows for genetic alteration of the insect to carry a genotype that over expresses or under expresses certain genes, resulting in the death of the progeny.

Problems solved by technology

Insect-borne diseases are a huge and growing problem in world health.

Although the mortality occurs among young children in sub-Saharan Africa, malaria still poses a health risk in the United States, with approximately 3000 cases being reported in 2000-2001 alone.

The other concern relates to the general safety and efficacy of the use of insecticides, specifically, some insecticides such as the group of insecticide compounds known as the organophosphates, affect vertebrate nervous systems, and therefore pose a risk to human and animal populations.

Using this selection, Keppy and Denell were able to obtain duplications and deficiencies of Tpl, but were unable to isolate point mutations following EMS or formaldehyde mutagenesis.

However, we have subsequently screened more than 106 chromosomes and still have not isolated point mutants.

Images